Sign Up Today and Learn More About Rgenix Stock
Invest in or calculate the value of your shares in Rgenix or other pre-IPO companies through EquityZen's platform.
Rgenix Stock (RGEN)
Rgenix is a a discovery platform, revolutionizing the treatment of cancer by generating first-in-class therapeutics.
About Rgenix Stock
Founded
2010
Headquarters
New York, NY, US
Total Funding
83.5M
Industries
Software, Data and Analytics, Artificial Intelligence
Rgenix Press Mentions
Stay in the know about the latest news on Rgenix
Inspirna Announces Appointment of Karim Benhadji, M.D., as Chief Medical Officer and Retirement of Robert Wasserman, M.D.
businesswire • May 21, 2024
Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
businesswire • Feb 19, 2024
Regeneron’s odronextamab granted FDA priority review for ...
pmlive • Jan 19, 2024
Capital Markets Day 2023 | Merck
merckgroup • Jan 19, 2024
ADC licensing deals reached peak of $16.6 billion in 2022
biopharma-reporter • Jan 19, 2024
Rgenix Management
Leadership team at Rgenix
CFO
David Darst
Co-Founder
Masoud Tavazoie
Join now and verify your accreditation status to gain access to:
- Rgenix current valuation
- Rgenix stock price
- Available deals in Rgenix and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Rgenix stock?
Accredited investors can buy pre-IPO stock in companies like Rgenix through EquityZen funds. These investments are made available by existing Rgenix shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Rgenix stock?
Shareholders can sell their Rgenix stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
